
TrueBlue rose 142.0% from $5.24 to a 1-year high of $12.68, ahead of the S&P 500's +9.8%. Its worst day was Feb 19 (−13.5%), and its low came Mar 27 at $3.31.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.25 missed the $-0.06 estimate on $418.2M revenue (est. $413.3M); Q1 revenue guidance of $381.0M–$406.0M against the $386.5M consensus.
−13.5%, the year's worst day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
TrueBlue closed at its lowest level of the year, 36.8% below where the year started.
−6.8% · S&P 500 −1.7%
EPS of $-0.41 beat the $-0.45 estimate on $398.6M revenue (est. $390.1M); Q2 revenue guidance of $405.0M–$430.0M against the $416.4M consensus.
+0.2% · S&P 500 +1.4%
TrueBlue shares rose 21.0%, while the S&P 500 rose 0.9%.
+21.0% · S&P 500 +0.9%
EPS of $0.06 beat the $-0.10 estimate on $443.0M revenue (est. $416.2M); Q3 revenue guidance of $461.0M–$481.0M against the $452.9M consensus.
+28.7%, the year's best day · S&P 500 −0.2%
EPS of $0.33 beat the $0.19 estimate on $520.7M revenue (est. $467.4M); Q4 revenue guidance of $499.0M–$519.0M against the $435.4M consensus.
+25.6% · S&P 500 −4.4%
Where it ended: a 1-year high close of $12.68 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 17, 2027 (EPS est. $0.08, revenue est. $476.5M).
Nothing in the past 12 months.
All TBI analyst actionsNothing in the past 12 months.
All TBI dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TBI and SPY from Benzinga historical bars. Not investment advice.